Perflubutane
Key facts
| Active substance |
Perflubutane
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/106/2008
|
| PIP number |
Perflubutane
|
| Pharmaceutical form(s) |
Lyophilisate for suspension for injection
|
| Condition(s) / indication(s) |
Visualisation of myocardial perfusion for diagnostic purposes
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Nycomed Danmark ApS
E-mail: kristina.allikmets@nycomed.com |
| Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|